動画検索
関連広告
検索結果
Background
Resistance to Targeted Therapy in RCC
Sorafenib resistant tumors remain sensitive to repeat sorafenib
The same anti-VEGF drug works after prior resistance
AXIS Study Design
Everolimus Phase 3 Study (RECORD-1) - Design and Prior Therapy
Median PFS in Treatment-Refractory RCC
Median PFS in Sunitinib-Refractory RCC
Summary of Axitinib PFS by Duration of Prior Sunitinib
Conclusions